FindMyKOL
Clinical trialNCT00640614CompletedPhase 3Interventional

Clinical Evaluation of T.R.U.E. TEST® : Safety and Efficacy

SponsorAllerdermEnrollment235Contact Dermatitis
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

We propose an open, prospective, multi-center Phase III study to evaluate the diagnostic performance and safety of seven new T.R.U.E. Test allergens: Gold sodium thiosulfate, Hydrocortisone-17-butyrate, Bacitracin, Parthenolide, Methyldibromoglutaronitrile, Disperse blue 106, and Bronopol.Allergen performance and safety will be evaluated in adult patients with suspected contact dermatitis, and in adult patients with a known or suspected sensitization to at least one of the seven allergens.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Denmark
  • Odense University Hospital

    Odense C, Denmark

United States
  • River City Dermatology

    Little Rock, Arkansas, United States

  • American Dermatology Associates

    Shawnee Mission, Kansas, United States

  • Dermatology Specialists Psc

    Louisville, Kentucky, United States

  • Winthrop University Hospital

    Mineola, New York, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

T.R.U.E. TEST® Skin Patch Test: Dose Response Allergens
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Apr 2008
Primary completion
31 Aug 2009
Completion
31 Oct 2009
Last update posted
5 May 2020
Registered enrollment
235
Registry id
NCT00640614

Cross-registrations

EU-CTR / CTIS (EudraCT)2008-000168-18
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.